Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-279709
Filing Date
2024-12-16
Accepted
2024-12-16 17:18:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d853760d424b5.htm 424B5 434216
2 GRAPHIC g853760g01k01.jpg GRAPHIC 611311
  Complete submission text file 0001193125-24-279709.txt   1268426
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273030 | Film No.: 241552821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)